129 related articles for article (PubMed ID: 25130928)
1. Anatomical localization of p53 mutated tumors: A radiographic study of human glioblastomas.
Zhang T; Wang Y; Fan X; Ma J; Li S; Jiang T; Wang L
J Neurol Sci; 2014 Nov; 346(1-2):94-8. PubMed ID: 25130928
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma.
Aghi M; Gaviani P; Henson JW; Batchelor TT; Louis DN; Barker FG
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8600-5. PubMed ID: 16361543
[TBL] [Abstract][Full Text] [Related]
3. Correlation Between Tumor Location and Clinical Properties of Glioblastomas in Frontal and Temporal Lobes.
Li HY; Sun CR; He M; Yin LC; Du HG; Zhang JM
World Neurosurg; 2018 Apr; 112():e407-e414. PubMed ID: 29355809
[TBL] [Abstract][Full Text] [Related]
4. Correlation among pathology, genotype, and patient outcomes in glioblastoma.
Homma T; Fukushima T; Vaccarella S; Yonekawa Y; Di Patre PL; Franceschi S; Ohgaki H
J Neuropathol Exp Neurol; 2006 Sep; 65(9):846-54. PubMed ID: 16957578
[TBL] [Abstract][Full Text] [Related]
5. Absence of p53 autoantibodies in sera from glioma patients.
Rainov NG; Dobberstein KU; Fittkau M; Bahn H; Holzhausen HJ; Gantchev L; Burkert W
Clin Cancer Res; 1995 Jul; 1(7):775-81. PubMed ID: 9816045
[TBL] [Abstract][Full Text] [Related]
6. Mapping p53 mutations in low-grade glioma: a voxel-based neuroimaging analysis.
Wang YY; Zhang T; Li SW; Qian TY; Fan X; Peng XX; Ma J; Wang L; Jiang T
AJNR Am J Neuroradiol; 2015 Jan; 36(1):70-6. PubMed ID: 25104286
[TBL] [Abstract][Full Text] [Related]
7. Elimination of wild-type P53 mRNA in glioblastomas showing heterozygous mutations of P53.
Szybka M; Zawlik I; Kulczycka D; Golanska E; Jesien E; Kupnicka D; Stawski R; Piaskowski S; Bieniek E; Zakrzewska M; Kordek R; Liberski PP; Rieske P
Br J Cancer; 2008 Apr; 98(8):1431-3. PubMed ID: 18349850
[TBL] [Abstract][Full Text] [Related]
8. Neuroimaging characteristics in subgroup of GBMs with p53 overexpression.
Mut M; Turba UC; Botella AC; Baskurt E; Lopes MB; Shaffrey ME
J Neuroimaging; 2007 Apr; 17(2):168-74. PubMed ID: 17441839
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetic analysis of deep-seated glioblastomas.
Hayashi Y; Yamashita J; Watanabe T
Cancer Genet Cytogenet; 2004 Aug; 153(1):64-8. PubMed ID: 15325097
[TBL] [Abstract][Full Text] [Related]
10. A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme.
Newcomb EW; Madonia WJ; Pisharody S; Lang FF; Koslow M; Miller DC
Brain Pathol; 1993 Jul; 3(3):229-35. PubMed ID: 8293182
[TBL] [Abstract][Full Text] [Related]
11. p53 and disease: when the guardian angel fails.
Royds JA; Iacopetta B
Cell Death Differ; 2006 Jun; 13(6):1017-26. PubMed ID: 16557268
[TBL] [Abstract][Full Text] [Related]
12. Homozygous p53 gene mutation in a radiation-induced glioblastoma 10 years after treatment for an intracranial germ cell tumor: case report.
Tada M; Sawamura Y; Abe H; Iggo R
Neurosurgery; 1997 Feb; 40(2):393-6. PubMed ID: 9007876
[TBL] [Abstract][Full Text] [Related]
13. Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblastomas.
Sure U; Rüedi D; Tachibana O; Yonekawa Y; Ohgaki H; Kleihues P; Hegi ME
J Neuropathol Exp Neurol; 1997 Jul; 56(7):782-9. PubMed ID: 9210874
[TBL] [Abstract][Full Text] [Related]
14. Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses.
Tada M; Iggo RD; Waridel F; Nozaki M; Matsumoto R; Sawamura Y; Shinohe Y; Ikeda J; Abe H
Mol Carcinog; 1997 Mar; 18(3):171-6. PubMed ID: 9115587
[TBL] [Abstract][Full Text] [Related]
15. Molecular heterogeneity of glioblastomas: does location matter?
Denicolaï E; Tabouret E; Colin C; Metellus P; Nanni I; Boucard C; Tchoghandjian A; Meyronet D; Baeza-Kallee N; Chinot O; Figarella-Branger D
Oncotarget; 2016 Jan; 7(1):902-13. PubMed ID: 26637806
[TBL] [Abstract][Full Text] [Related]
16. The definition of primary and secondary glioblastoma.
Ohgaki H; Kleihues P
Clin Cancer Res; 2013 Feb; 19(4):764-72. PubMed ID: 23209033
[TBL] [Abstract][Full Text] [Related]
17. Regional specificity of matrix metalloproteinase-9 expression in the brain: voxel-level mapping in primary glioblastomas.
Fan X; Qi C; Liu X; Wang Y; Liu S; Li S; Wang L; Wang Y
Clin Radiol; 2018 Mar; 73(3):283-289. PubMed ID: 29187298
[TBL] [Abstract][Full Text] [Related]
18. TERT promoter mutations in primary and secondary glioblastomas.
Nonoguchi N; Ohta T; Oh JE; Kim YH; Kleihues P; Ohgaki H
Acta Neuropathol; 2013 Dec; 126(6):931-7. PubMed ID: 23955565
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation.
Leung SY; Yuen ST; Chan TL; Chan AS; Ho JW; Kwan K; Fan YW; Hung KN; Chung LP; Wyllie AH
Oncogene; 2000 Aug; 19(35):4079-83. PubMed ID: 10962567
[TBL] [Abstract][Full Text] [Related]
20. p53 status has no prognostic significance in glioblastomas treated with radiotherapy.
Baxendine-Jones J; Campbell I; Ellison D
Clin Neuropathol; 1997; 16(6):332-6. PubMed ID: 9401801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
